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The relationship between nitrate ad-
ministration and viability detection
dates back many years. Already in the
1970s, various groups had demon-
strated that an improvement in regional
left ventricular function produced by
the acute administration of nitrates was
related to a subsequent favorable re-
sponse after coronary bypass surgery
(1,2). In particular, Helfant et al. (1)
showed that 15 of 18 asynergic seg-
ments with improvement after sublin-
gual nitroglycerin had a similar improve-
ment after bypass grafting, whereas the 2
segments with persistent dysfunction af-
ter nitroglycerin were unchanged even
after bypass surgery. Similarly, Chese-
bro et al. (2) observed a good correlation
between the changes in wall thickening
produced by sublingual nitroglycerin
and those registered several months after
bypass surgery. Giving a histologic sub-
strate to these clinical observations,
Bodenheimer et al. (3) detected a lower
degree of fibrosis in the nitrate-respon-
sive segments than in the other asynergic
segments. To explain these data, various
mechanisms of action were suggested.
Certainly, nitrates positively affect the
relationship between myocardial oxygen
supply and demand, mainly through the
reduction in preload and afterload of the
ventricles (4). However, it was also sug-
gested that at least part of this effect was
caused by a direct action on coronary
circulation, either by vasodilatation of
stenoses or by redistribution of flow to
the ischemic areas, particularly through
collateral vessels (5,6). The role of col-
lateral circulation was confirmed in ani-
mal experiments by Hisano et al., who
demonstrated that the improvement in
regional function under isosorbide di-
nitrate was related to the degree of de-
velopment of collaterals (7). In humans,
Fujita et al. (8) observed that in patients
in whom the territory of a completely
occluded left ventricular descending ar-
tery was supplied by a good collateral
circulation, both global and regional
function improved significantly after
sublingual nitroglycerin, whereas no
change was registered in the remaining
patients with occlusion but without col-
laterals. In all the above studies, atten-
tion was given mainly to the functional
changes induced by nitrate administra-
tion. However, in good agreement with
the hypothesis of a direct action on cor-
onary collateral circulation, Aoki et al.
demonstrated that in collateral-depen-
dent noninfarcted myocardium the acute
administration of nitroglycerin reduced
the extent and severity of the 201Tl myo-
cardial perfusion defect induced by ex-
ercise (9).
In the second half of the 1980s, the
concept of hibernating myocardium,
that is, chronic regional asynergia of
ischemic origin with reversible dys-
function after successful revasculariza-
tion, was introduced and deeply mod-
ified the diagnostic approach to heart
failure in patients with coronary artery
disease (10). Perfusion/metabolism im-
aging with PET emerged as the most
accurate test to detect viable hibernat-
ing myocardium and was found to be
more reliable than stress-redistribution
201Tl myocardial perfusion scintigra-
phy (11). To overcome the limitations
of stress-redistribution scans and be-
cause of the need to evaluate large
numbers of patients, modifications of
the standard 201Tl imaging protocol
were proposed. Delayed redistribution
(12), rest-reinjection (13), and rest-re-
distribution (14) were tested and had
good results for viability detection.
The possibility of using the acute ef-
fects of nitrate on coronary blood flow
to improve the detection of viable hi-
bernating myocardium was examined
for the first time by He et al., who
demonstrated the increase in 201Tl de-
fect reversibility if the tracer was rein-
jected after isosorbide dinitrate admin-
istration (15). However, because all of
the various protocols proposed for vi-
ability detection were effective, ni-
trate-enhanced imaging was not con-
sidered essential if 201Tl was chosen as
the perfusion agent. In the case of
99mTc-labeled perfusion tracers, sev-
eral early reports suggested an under-
estimation of myocardial viability in
the standard resting images obtained
using these agents (16,17). The imag-
ing protocol modifications used for
201Tl imaging were hardly feasible
with the 99mTc-labeled perfusion trac-
ers, although resting 99mTc-sestamibi
quantitative SPECT (18) and redistri-
bution images (19) were reported to
achieve quite good results. In contrast,
the experimental data clearly showed
that all 99mTc-labeled agents available
for clinical use (99mTc-sestamibi,
99mTc-teboroxime, and 99mTc-tetrofos-
min) were not just pure flow tracers but
also required myocyte viability to be
retained within the myocardium
(20–22). Therefore, the use of nitrate
enhancement appeared an attractive
approach to improve their ability to
recognize viable myocardium. Bisi et
al. observed that stress defect revers-
ibility in resting 99mTc-teboroxime im-
ages was greater after nitrate enhance-
ment, with a closer agreement to 201Tl
reinjection data (23). In patients with
previous myocardial infarction, Galli
et al. found a sizable decrease in rest-
ing 99mTc-sestamibi uptake defects af-
ter nitroglycerin administration in 20
of 36 subjects and correlated it with
indexes of likely preserved viability
(24). Finally, Bisi et al., using 99mTc-
sestamibi SPECT, demonstrated for
the first time a direct relationship be-
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tween nitrate-induced improvement in
myocardial perfusion and regional
functional recovery after coronary re-
vascularization (25). In a patient pop-
ulation with left ventricular dysfunc-
tion and coronary artery disease that
underwent successful revasculariza-
tion, 7 patients showed significant
functional recovery in at least 1 dys-
functional coronary territory and 11
showed an unchanged wall motion pat-
tern in all asynergic territories: In the
first group a decrease in the extent of
the baseline perfusion defect was ob-
served after isosorbide dinitrate infu-
sion (37.4%  21.6%), whereas in
the second group no change in perfu-
sion defect extent was registered in
nitrate-enhanced imaging (5.8% 
8.4%, P  0.0005 vs. the first group).
Since then, several articles have con-
firmed the reliability of nitrate 99mTc-
sestamibi scintigraphy for the recogni-
tion of viable myocardium within
dysfunctional segments and the predic-
tion of regional functional recovery
(26–29). Similarly, nitrate administra-
tion increased the rate of defect revers-
ibility in 99mTc-tetrofosmin scintigra-
phy and improved its agreement with
201Tl (30,31). Even the use of 201Tl
nitrate-enhanced imaging was con-
firmed to be helpful for viability detec-
tion (32).
Despite the general agreement that
the results of nitrate-enhanced perfu-
sion imaging for predicting regional
improvement compare well with other
established methods (33), a clear-cut
demonstration of the effects of nitrate
administration on coronary circulation
in the setting of viable dysfunctional
myocardium was still lacking. Using
PET and 13NH3, Fallen et al. had dem-
onstrated that the topical application of
nitroglycerin produced a preferential
increase in tracer retention in ischemic
versus nonischemic segments (34).
Their patient population, however, did
not include patients with left ventricu-
lar dysfunction, and the segment char-
acterization was based on a stress-in-
duced 201Tl defect; thus, there was no
clear relationship between a preferen-
tial nitrate-induced increase in coro-
nary blood flow and myocardial viabil-
ity. The study by Tadamura et al. (35)
that appears in this issue of The Jour-
nal of Nuclear Medicine tries to fill this
gap, examining the changes induced
by the acute administration of nitro-
glycerin on coronary blood flow in dif-
ferent groups of myocardial segments
classified on the basis of one of the
currently used techniques for viability
detection, that is, 201Tl rest-redistribu-
tion SPECT. The authors identify 4
groups of regions: segments with nor-
mal uptake, segments with reversible
defect (ischemic), segments with mild-
to-moderate fixed defect (viable), and
segments with severe fixed defect
(nonviable). Measuring the absolute
myocardial blood flow with 15O-water,
the authors observed a preserved myo-
cardial blood flow in front of a de-
crease in systemic arterial pressure in
the segments classified as either ische-
mic or viable; this result was produced
by a selective decrease in coronary
vascular resistance in these 2 groups of
segments (from 141  50 to 114  29
mm Hg/[mL/min/g], P  0.004, and
from 165  64 to 149  60 mm Hg/
[mL/min/g], P  0.003, in the ische-
mic and in the viable segments, respec-
tively). Conversely, both the normal
segments and those with a persistent
severe reduction in 201Tl uptake
showed a decrease in myocardial blood
flow after nitrate administration be-
cause the drop in arterial pressure was
not compensated for by a reduction in
coronary vascular resistance. These re-
sults are interesting because they are
the first direct demonstration that the
effects of acute nitrate administration
on coronary blood flow are not only
selective but also remarkably favorable
for the detection of ischemic viable
myocardium. Thus, Tadamura et al.
give a physiopathologic support to the
above-mentioned clinical studies re-
porting the accuracy of nitrate-en-
hanced imaging protocols for the issue
of viability detection. However, vari-
ous problems still remain.
First, and as recognized by the au-
thors, the limitations of the study must
be considered. The patient population
is not one for which the issue of via-
bility is of major clinical relevance be-
cause most patients had a normal or
near-normal left ventricular function
and only 9 of 23 patients had a left
ventricular ejection fraction  40%.
Also, the reference method used by
Tadamura et al. (35) to define the via-
bility status of the myocardial seg-
ments is not optimal. Although widely
used in clinical practice, 201Tl rest-re-
distribution cannot be considered the
ultimate standard of myocardial viabil-
ity. In particular, the specificity of this
technique is well known to be rela-
tively low (33). It is reasonable to as-
sume that at least part of the segments
considered viable according to the rest-
redistribution scan result were not lia-
ble to functionally improve after revas-
cularization and were hence nonviable
according to the prevailing notion.
Furthermore, no functional correlates
of 201Tl uptake have been examined, so
that it is impossible to understand
whether there is a relationship between
degree of functional impairment and
nitrate-induced changes in coronary
vascular resistance. Certainly, these
limitations in patient selection and
study protocol do not cancel the value
of the report by Tadamura et al. but
require that further studies be per-
formed in which myocardial blood
flow measurement under nitrate is ex-
amined while taking into account both
baseline regional function and its evo-
lution after revascularization.
Other problems are related to the
more general issue of the role of base-
line resting hypoperfusion in determin-
ing reversible dysfunction of the myo-
cardium. The demonstration that
nitrates induce a decrease in coronary
vascular resistance in viable segments
agrees with the classic concept that
reversible dysfunction is caused by a
status of chronic hypoperfusion (10).
This concept, however, is not unani-
mously accepted, and the possibility
that reversible dysfunction is caused
by a status of repeated stunning in the
presence of a severe reduction in cor-
onary reserve, but with preserved rest-
ing perfusion, must be considered (36).
Most probably, there is a continuous
spectrum of conditions ranging from
true hibernation to minimal-threshold
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ischemia with repetitive stunning (37). It
is reasonable to hypothesize that the role
of nitrate imaging could be slightly dif-
ferent under these conditions. Particu-
larly with 99mTc-labeled perfusion trac-
ers, and so excluding the effects of
redistribution, resting uptake should
usually be preserved in the case of
chronic stunning, similarly to what has
been already demonstrated after acute
myocardial infarction treated by effec-
tive reperfusion (38), whereas nitrate
administration would be necessary to
allow a recognizable uptake in seg-
ments with true hibernation. If this hy-
pothesis were true, nitrate imaging
could be useful not only to overcome
the imaging limitations of nonredis-
tributing 99mTc-labeled perfusion trac-
ers but also to differentiate between the
2 different conditions of reversible is-
chemic dysfunction. This problem
could have important clinical implica-
tions. For instance, a different time
course of functional recovery after re-
vascularization in hibernating versus
stunned myocardium has been ob-
served (39). Furthermore, it cannot be
excluded that hibernation and chronic
stunning have different prognostic im-
plications.
Another point to be clarified is
whether the response to nitrate admin-
istration could be helpful to differenti-
ate between viable myocardium liable
to functionally improve after revascu-
larization versus partially preserved vi-
ability in the instance of nontransmural
necrosis, which could be valuable to
prevent ventricular remodeling but
should not be expected to recover after
revascularization (40). In other words,
nitrate imaging could play a role in
improvement of the specificity of myo-
cardial perfusion SPECT for the issue
of viability detection, at least in terms
of recognition of reversible dysfunc-
tion.
In conclusion, the study by Tad-
amura et al. (35) gives important sup-
port to the use of nitrate-enhanced imag-
ing for the detection of viable
myocardium. At the same time, it also
justifies the need for further studies to
improve our knowledge of the different
physiopathologic conditions that subtend
the presence of ischemic and possibly
reversible myocardial dysfunction. Ni-
trate-enhanced imaging could play an in-
teresting role in this kind of study about
myocardial viability. The story of this
durable affair goes on.
Roberto Sciagra`, MD
University of Florence
Florence, Italy
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